Computed cancer interactome explains the effects of somatic mutations in cancers

被引:14
|
作者
Zhang, Jing [1 ,2 ]
Pei, Jimin [1 ,2 ]
Durham, Jesse [1 ,2 ]
Bos, Tasia [1 ,2 ]
Cong, Qian [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA
关键词
AlphaFold; cancer mutations; protein-protein interactions; structure prediction; cancer interactome; PROTEOME-SCALE MAP; STRUCTURAL BASIS; TUMOR-SUPPRESSOR; ATAXIA-TELANGIECTASIA; BRCT DOMAIN; GENE; BREAST; RECOGNITION; EXPRESSION; PROTEINS;
D O I
10.1002/pro.4479
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions (PPIs) are involved in almost all essential cellular processes. Perturbation of PPI networks plays critical roles in tumorigenesis, cancer progression, and metastasis. While numerous high-throughput experiments have produced a vast amount of data for PPIs, these data sets suffer from high false positive rates and exhibit a high degree of discrepancy. Coevolution of amino acid positions between protein pairs has proven to be useful in identifying interacting proteins and providing structural details of the interaction interfaces with the help of deep learning methods like AlphaFold (AF). In this study, we applied AF to investigate the cancer protein-protein interactome. We predicted 1,798 PPIs for cancer driver proteins involved in diverse cellular processes such as transcription regulation, signal transduction, DNA repair, and cell cycle. We modeled the spatial structures for the predicted binary protein complexes, 1,087 of which lacked previous 3D structure information. Our predictions offer novel structural insight into many cancer-related processes such as the MAP kinase cascade and Fanconi anemia pathway. We further investigated the cancer mutation landscape by mapping somatic missense mutations (SMMs) in cancer to the predicted PPI interfaces and performing enrichment and depletion analyses. Interfaces enriched or depleted with SMMs exhibit different preferences for functional categories. Interfaces enriched in mutations tend to function in pathways that are deregulated in cancers and they may help explain the molecular mechanisms of cancers in patients; interfaces lacking mutations appear to be essential for the survival of cancer cells and thus may be future targets for PPI modulating drugs.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Landscape of somatic genetic alterations in endometrioid endometrial cancers with germline and somatic PTEN mutations
    Ashley, C. W.
    Selenica, P.
    Caldero, S. G.
    Tuset-DerAbrain, N.
    Reis-Filho, J.
    Matias-Guiu, X.
    Weigelt, B.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 60 - 60
  • [22] The prognostic effects of somatic mutations in ER-positive breast cancer
    Obi L. Griffith
    Nicholas C. Spies
    Meenakshi Anurag
    Malachi Griffith
    Jingqin Luo
    Dongsheng Tu
    Belinda Yeo
    Jason Kunisaki
    Christopher A Miller
    Kilannin Krysiak
    Jasreet Hundal
    Benjamin J Ainscough
    Zachary L. Skidmore
    Katie Campbell
    Runjun Kumar
    Catrina Fronick
    Lisa Cook
    Jacqueline E. Snider
    Sherri Davies
    Shyam M. Kavuri
    Eric C. Chang
    Vincent Magrini
    David E. Larson
    Robert S Fulton
    Shuzhen Liu
    Samuel Leung
    David Voduc
    Ron Bose
    Mitch Dowsett
    Richard K. Wilson
    Torsten O. Nielsen
    Elaine R Mardis
    Matthew J. Ellis
    Nature Communications, 9
  • [23] Retention of Somatic Mutations in Cancers by Gain in pH Sensing.
    White, K. A.
    Szpiech, Z. A.
    Ruiz, D. Garrido
    Strauli, N. B.
    Jacobson, M. P.
    Hernandez, R.
    Barber, D. L.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [24] Detecting epistatic effects among somatic cancer mutations across oncogenesis
    Alfaro-Murillo, Jorge A.
    Dasari, Krishna
    Townsend, Jeffrey P.
    CANCER RESEARCH, 2024, 84 (03)
  • [25] The prognostic effects of somatic mutations in ER-positive breast cancer
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    NATURE COMMUNICATIONS, 2018, 9
  • [26] Noninvasive genomic profiling of somatic mutations in oral cavity cancers
    Xi, Yuanxin
    Negrao, Marcelo V.
    Akagi, Keiko
    Xiao, Weihong
    Jiang, Bo
    Warner, Sarah C.
    Dunn, Joe Dan
    Wang, Jing
    Symer, David E.
    Gillison, Maura L.
    ORAL ONCOLOGY, 2023, 140
  • [27] Somatic mutations of CASP3 gene in human cancers
    Soung, YH
    Lee, JW
    Kim, SY
    Park, WS
    Nam, SW
    Lee, JY
    Yoo, NJ
    Lee, SH
    HUMAN GENETICS, 2004, 115 (02) : 112 - 115
  • [28] Functional annotation of the Hippo pathway somatic mutations in human cancers
    Han, Han
    Huang, Zhen
    Xu, Congsheng
    Seo, Gayoung
    An, Jeongmin
    Yang, Bing
    Liu, Yuhan
    Lan, Tian
    Yan, Jiachen
    Ren, Shanshan
    Xu, Yue
    Xiao, Di
    Yan, Jonathan K.
    Ahn, Claire
    Fishman, Dmitry A.
    Meng, Zhipeng
    Guan, Kun-Liang
    Qi, Ruxi
    Luo, Ray
    Wang, Wenqi
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [29] Somatic mutations of CASP3 gene in human cancers
    Young Hwa Soung
    Jong Woo Lee
    Su Young Kim
    Won Sang Park
    Suk Woo Nam
    Jung Young Lee
    Nam Jin Yoo
    Sug Hyung Lee
    Human Genetics, 2004, 115 : 112 - 115
  • [30] Intratumoral heterogeneity of FLCN somatic mutations in gastric and colorectal cancers
    Son, Hyun Ji
    Choi, Eun Ji
    Yoo, Nam Jin
    Lee, Sug Hyung
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2811 - 2812